Visceral leishmaniasis in Afghanistan
- Treatment of American Cutaneous Leishmaniasis with Miltefosine, an Oral Agent. Soto, J.; Toledo, J.; Gutierrez, P.; Nicholls, R. S.; Padilla, J.; Engel, J.; Fischer, C.; Voss, A.; Berman, J. // Clinical Infectious Diseases;10/1/2001, Vol. 33 Issue 7, pe57
There is no recognized oral treatment for American cutaneous leishmaniasis. A rising-dose, open-label phase I/II trial of the oral agent miltefosine against Colombian cutaneous leishmaniasis was conducted. Seventy-two male Colombian soldiers (mean weight, 67 kg) received miltefosine at 50--100...
- Spatial and temporal variation and hotspot detection of kala-azar disease in Vaishali district (Bihar), India. Bhunia, Gouri Sankar; Kesari, Shreekant; Chatterjee, Nandini; Kumar, Vijay; Das, Pradeep // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1
Background: An improved understanding in transmission variation of kala-azar is fundamental to conduct surveillance and implementing disease prevention strategies. This study investigated the spatio-temporal patterns and hotspot detection for reporting kala-azar cases in Vaishali district based...
- Infectious disease: Combating visceral leishmaniasis. Harrison, Charlotte // Nature Reviews Drug Discovery;Nov2013, Vol. 12 Issue 11, p828
The article discusses a research on the treatment of visceral leishmaniasis which references the study "Vaccination with Leishmania hemoglobin receptor-encoding DNA protects against visceral leishmanias," by R. Guha and colleagues in the 2013 issue of "Science Translational Medicine"
- Kala-azar epidemic in Varanasi district, India. Kumar, R.; Kumar, P. // Bulletin of the World Health Organization;1999, Vol. 77 Issue 5, p371
Attempts to discover the epidemiological characteristics of the kala-azar outbreak in Varanasi district, India. History of fever and hepatosplenomegaly in all the cases; High disease prevalence among adults.
- Visceral Leishmaniasis in the Indian Subcontinent: Modelling Epidemiology and Control. Stauch, Anette; Sarkar, Ram Rup; Picado, Albert; Ostyn, Bart; Sundar, Shyam; Rijal, Suman; Boelaert, Marleen; Dujardin, Jean-Claude; Duerr, Hans-Peter // PLoS Neglected Tropical Diseases;Nov2011, Vol. 5 Issue 11, p1
Background: In the Indian subcontinent, about 200 million people are at risk of developing visceral leishmaniasis (VL). In 2005, the governments of India, Nepal and Bangladesh started the first regional VL elimination program with the aim to reduce the annual incidence to less than 1 per 10,000...
- Abstracts. Smith, Jeanette M. // JAMA: Journal of the American Medical Association;8/9/95, Vol. 274 Issue 6, p444q
Presents an abstract of the article `Endemic Kala-azar in Eastern Sudan: Post-Kala-azar Dermal Leishmaniasis,' by E.E. Ziglstra et al.
- New therapy for visceral leishmaniasis. // Weekly Epidemiological Record;6/21/2002, Vol. 77 Issue 25, p210
Reports on the use of miltefosine, manufactured by German pharmaceutical company Zentaris, as a chemotherapeutic agent for oral administration against the parasitic disease leishmaniasis. Transmission of leishmaniasis through the bite of the sandfly; Clinical trials conforming to international...
- Control of visceral leishmaniasis in Brazil:recommendations from Brasileish. Ribeiro, Vitor Márcio; da Silva, Sydnei Magno; Menz, Ingrid; Tabanez, Paulo; Santos Nogueira, Fábio dos; Werkhaüser, Manfredo; da Fonseca, André Luis S.; Dantas-Torres, Filipe // Parasites & Vectors;2013, Vol. 6 Issue 1, p1
On 26 October 2012, veterinary medicine clinicians and researchers, members of Brasileish - Study Group about Animal Leishmaniasis - met at the Regional Council of Veterinary Medicine of Minas Gerais, in the city Belo Horizonte, in order to discuss many aspects of the situation of canine...
- Kala-Azar Elimination in Bihar: Adoption of Newer Evidence-based Strategies Required for Elimination. Soni, Prashant; Mishra, Ragini; Kumar, Ganga; Pandey, Prabhat; Kumar, Prashant // Middle East Journal of Scientific Research;2013, Vol. 17 Issue 9, p1220
Kala-azar i.e, Visceral Leishmaniasis (VL) is a menace to Bihar, affecting large number of population. As per WHO, one-third cases of Kala-azar are reported from Bihar itself. Diagnosis and case detection is done by rk39. Miltefosine has been rolled out in 16 highly endemic districts of Bihar;...